EC Number   |
Disease |
PubMed ID  |
Title of Publication |
Category |
Confidence Level |
|---|
    3.5.3.1 | Anaplasmosis |
2763451 |
Enzymes of oxidant defence system of leucocytes and erythrocytes in bovine anaplasmosis. |
unassigned |
0 |
| 3.5.3.1 | Stomach Neoplasms |
2819664 |
Content of glucocorticoid receptor and arginase in gastric cancer and normal gastric mucosal tissues. |
causal interaction
diagnostic usage
ongoing research
unassigned |
4
3
4
0 |
| 3.5.3.1 | Infections |
2860832 |
Diagnosis of Fasciola hepatica infection in beef calves by plasma enzyme analysis. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
4
2
1 |
| 3.5.3.1 | Cholestasis |
2889412 |
Alterations in selected serum biochemical constituents in equids after induced hepatic disease. |
diagnostic usage
ongoing research
unassigned |
2
3
0 |
| 3.5.3.1 | Neoplasms |
2895650 |
Hypolipidemic drug clofibrate induces hepatic dedifferentiation. |
unassigned |
0 |
| 3.5.3.1 | Hyperargininemia |
2913054 |
Differential expression of the two human arginase genes in hyperargininemia. Enzymatic, pathologic, and molecular analysis. |
diagnostic usage
ongoing research
unassigned |
3
2
0 |
| 3.5.3.1 | Herpes Simplex |
2983142 |
[Polyvinylpyrrolidone iodine and arginase: effect on corneal regeneration and its antiviral effect] |
therapeutic application
unassigned |
2
0 |
| 3.5.3.1 | arginase deficiency |
3104676 |
A new case of arginase deficiency in a Spanish male. |
causal interaction
ongoing research
unassigned |
1
1
0 |
| 3.5.3.1 | Hyperargininemia |
3104676 |
A new case of arginase deficiency in a Spanish male. |
causal interaction
ongoing research
unassigned |
1
1
0 |
| 3.5.3.1 | Hyperargininemia |
3117587 |
Purification, modification, physico-chemical and pharmacokinetic characterization of arginase, an enzyme of potential use in therapy. |
causal interaction
therapeutic application
unassigned |
1
1
0 |
| 3.5.3.1 | Neoplasms |
3117587 |
Purification, modification, physico-chemical and pharmacokinetic characterization of arginase, an enzyme of potential use in therapy. |
causal interaction
therapeutic application
unassigned |
1
1
0 |
| 3.5.3.1 | Neoplasms |
3155494 |
Enzyme activities in prostatic carcinoma related to Gleason grades. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
4
2
1
0 |
| 3.5.3.1 | Neoplasms |
3435681 |
Effects of female sex steroids on concanavalin A-mediated agglutination of hepatocytes from nonregenerating and regenerating rat liver and hepatic tumor marker enzymes. |
unassigned |
0 |
| 3.5.3.1 | arginase deficiency |
3447498 |
[Arginase deficiency, congenital hypothyroidism and hepatic fibrosis] |
causal interaction
unassigned |
4
0 |
| 3.5.3.1 | Congenital Hypothyroidism |
3447498 |
[Arginase deficiency, congenital hypothyroidism and hepatic fibrosis] |
causal interaction
unassigned |
4
0 |
| 3.5.3.1 | Hyperargininemia |
3447498 |
[Arginase deficiency, congenital hypothyroidism and hepatic fibrosis] |
causal interaction
unassigned |
4
0 |
| 3.5.3.1 | Neoplasms |
3449318 |
The effects of arginase on neoplasm. I. The role of arginase in the immunosuppressive effects of extract from gastric cancer. |
causal interaction
diagnostic usage
ongoing research
unassigned |
4
4
4
0 |
| 3.5.3.1 | Stomach Neoplasms |
3449318 |
The effects of arginase on neoplasm. I. The role of arginase in the immunosuppressive effects of extract from gastric cancer. |
causal interaction
diagnostic usage
ongoing research
unassigned |
4
4
4
0 |
| 3.5.3.1 | Carcinoma, Hepatocellular |
3461568 |
Cloning of rat liver arginase cDNA and elucidation of regulation of arginase gene expression in H4 rat hepatoma cells. |
diagnostic usage
ongoing research
unassigned |
3
4
0 |
| 3.5.3.1 | arginase deficiency |
3540926 |
Pteridines and mono-amines: relevance to neurological damage. |
unassigned |
0 |
| 3.5.3.1 | Hyperargininemia |
3540926 |
Pteridines and mono-amines: relevance to neurological damage. |
unassigned |
0 |
| 3.5.3.1 | Hyperargininemia |
3540966 |
Molecular cloning and nucleotide sequence of cDNA for human liver arginase. |
ongoing research
unassigned |
4
0 |
| 3.5.3.1 | phenylalanine 4-monooxygenase deficiency |
3572445 |
Biopterins in arginase, dihydropteridine reductase and phenylalanine hydroxylase deficiency. |
unassigned |
0 |
| 3.5.3.1 | Phenylketonurias |
3572445 |
Biopterins in arginase, dihydropteridine reductase and phenylalanine hydroxylase deficiency. |
unassigned |
0 |
| 3.5.3.1 | arginase deficiency |
3632278 |
Liver fibrosis in arginase deficiency. |
causal interaction
unassigned |
4
0 |
| 3.5.3.1 | Hyperargininemia |
3632278 |
Liver fibrosis in arginase deficiency. |
causal interaction
unassigned |
4
0 |
| 3.5.3.1 | Liver Cirrhosis |
3632278 |
Liver fibrosis in arginase deficiency. |
causal interaction
unassigned |
4
0 |
| 3.5.3.1 | Neoplasms |
3698012 |
Effector mechanisms of human monocyte-mediated tumor cytotoxicity in vitro: biochemical, functional, and serological characterization of cytotoxins produced by peripheral blood monocytes isolated by counterflow elutriation. |
unassigned |
0 |
| 3.5.3.1 | Prolidase Deficiency |
3709569 |
Increased manganese content and reduced arginase activity in erythrocytes of a patient with prolidase deficiency (iminodipeptiduria). |
causal interaction
diagnostic usage
unassigned |
1
3
0 |
| 3.5.3.1 | xaa-pro dipeptidase deficiency |
3709569 |
Increased manganese content and reduced arginase activity in erythrocytes of a patient with prolidase deficiency (iminodipeptiduria). |
causal interaction
diagnostic usage
unassigned |
1
3
0 |
| 3.5.3.1 | Hyperargininemia |
3752085 |
The gene for human liver arginase (ARG1) is assigned to chromosome band 6q23. |
causal interaction
unassigned |
4
0 |
| 3.5.3.1 | arginase deficiency |
3760903 |
Arginase deficiency and phenylketonuria. |
unassigned |
0 |
| 3.5.3.1 | Hyperargininemia |
3760903 |
Arginase deficiency and phenylketonuria. |
unassigned |
0 |
| 3.5.3.1 | Phenylketonurias |
3760903 |
Arginase deficiency and phenylketonuria. |
unassigned |
0 |
| 3.5.3.1 | Brain Neoplasms |
3811280 |
[Comparative study of the activity of arginase isoenzymes in brain tumors of humans and experimental animals] |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
1
4
4
1 |
| 3.5.3.1 | Glioma |
3811280 |
[Comparative study of the activity of arginase isoenzymes in brain tumors of humans and experimental animals] |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
1
4
4
1 |
| 3.5.3.1 | Neoplasms |
3811280 |
[Comparative study of the activity of arginase isoenzymes in brain tumors of humans and experimental animals] |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
1
4
4
1 |
| 3.5.3.1 | Neoplasms, Nerve Tissue |
3811280 |
[Comparative study of the activity of arginase isoenzymes in brain tumors of humans and experimental animals] |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
1
4
4
1 |
| 3.5.3.1 | Neurilemmoma |
3811280 |
[Comparative study of the activity of arginase isoenzymes in brain tumors of humans and experimental animals] |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
1
4
4
1 |
| 3.5.3.1 | Liver Diseases |
3882282 |
Occurrence of cytotoxic autoantibody in rabbits by immunization with heterologous liver arginase: a possible implication in the mechanism of the autoimmune liver diseases. |
causal interaction
therapeutic application
unassigned |
3
3
0 |
| 3.5.3.1 | arginase deficiency |
3936352 |
Comparison of arginase activity in red blood cells of lower mammals, primates, and man: evolution to high activity in primates. |
causal interaction
unassigned |
1
0 |
| 3.5.3.1 | Hyperargininemia |
3936352 |
Comparison of arginase activity in red blood cells of lower mammals, primates, and man: evolution to high activity in primates. |
causal interaction
unassigned |
1
0 |
| 3.5.3.1 | arginase deficiency |
3943226 |
A simple quantitative micromethod of arginase assay in blood spots dried on filter paper. |
diagnostic usage
unassigned |
4
0 |
| 3.5.3.1 | Hyperargininemia |
3943226 |
A simple quantitative micromethod of arginase assay in blood spots dried on filter paper. |
diagnostic usage
unassigned |
4
0 |
| 3.5.3.1 | arginase deficiency |
3950825 |
Arginase deficiency in a 12-year-old boy with mild impairment of intellectual function. |
causal interaction
unassigned |
2
0 |
| 3.5.3.1 | Hyperargininemia |
3950825 |
Arginase deficiency in a 12-year-old boy with mild impairment of intellectual function. |
causal interaction
unassigned |
2
0 |
| 3.5.3.1 | Neoplasms |
4027373 |
[Changes in arginase activity during neurinoma growth] |
diagnostic usage
ongoing research
unassigned |
4
4
0 |
| 3.5.3.1 | Neurilemmoma |
4027373 |
[Changes in arginase activity during neurinoma growth] |
diagnostic usage
ongoing research
unassigned |
4
4
0 |
| 3.5.3.1 | arginase deficiency |
4078590 |
Impaired neurotransmitter amine metabolism in arginase deficiency. |
unassigned |
0 |
| 3.5.3.1 | Hyperargininemia |
4078590 |
Impaired neurotransmitter amine metabolism in arginase deficiency. |
unassigned |
0 |
| 3.5.3.1 | Neoplasms |
4090369 |
[Brain arginase isoenzyme activity during the growth of neurinomas] |
diagnostic usage
ongoing research
unassigned |
1
4
0 |
| 3.5.3.1 | Neurilemmoma |
4090369 |
[Brain arginase isoenzyme activity during the growth of neurinomas] |
diagnostic usage
ongoing research
unassigned |
1
4
0 |
| 3.5.3.1 | Neoplasms |
4119243 |
Arginase in human urogenital tumors. |
causal interaction
ongoing research
unassigned |
1
4
0 |
| 3.5.3.1 | Starvation |
4222567 |
The effect of adrenalectomy and starvation on arginase and ornithine-transcarbamylase activities in the liver of rats during development. |
ongoing research
unassigned |
4
0 |
| 3.5.3.1 | Neoplasms |
4315357 |
Arginase activity in nickel sulfide-induced rat tumors. |
ongoing research
unassigned |
1
0 |
| 3.5.3.1 | Fibrosarcoma |
4323137 |
Properties of arginase from SV40-induced hamster fibrosarcomas and hamster liver tissues. |
ongoing research
unassigned |
2
0 |
| 3.5.3.1 | Papilloma |
4331282 |
[Purification and properties of L-arginase of papillomas induced with the rabbit papilloma virus] |
ongoing research
unassigned |
2
0 |
| 3.5.3.1 | Tumor Virus Infections |
4331301 |
Change in the structure of Shope papilloma virus-induced arginase associated with mutation of the virus. |
unassigned |
0 |
| 3.5.3.1 | Hepatitis |
4344396 |
Identification of a canine adenovirus (infectious canine hepatitis virus) inhibitor in dog liver extracts as arginase. |
therapeutic application
unassigned |
2
0 |
| 3.5.3.1 | Tumor Virus Infections |
4348278 |
Induction of arginase activity with the Shope papilloma virus in tissue culture cells from an argininemic patient. |
ongoing research
unassigned |
4
0 |
| 3.5.3.1 | Starvation |
4370648 |
Intramitochondrial localization of arginase appearing in chicken liver upon starvation. |
unassigned |
0 |
| 3.5.3.1 | Neoplasms |
4421360 |
The inhibition of arginase by proline in cell-free extracts of mouse mammary tumour. |
causal interaction
therapeutic application
unassigned |
1
2
0 |
| 3.5.3.1 | Neoplasms |
4448486 |
Influence of hormonal status on arginase activity in mammary tissue and tumour. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
2
1
3
1 |
| 3.5.3.1 | Dehydration |
4541165 |
Adaptations of amphibian arginase. I. Response to dehydration. |
therapeutic application
unassigned |
1
0 |
| 3.5.3.1 | Liver Cirrhosis |
4584848 |
[Study of ureogenesis in liver cirrhosis by determination of ornithine carbamoyl- transferase and arginase activity in hepatic biopsy specimens] |
diagnostic usage
ongoing research
unassigned |
1
2
0 |
| 3.5.3.1 | arginase deficiency |
4625814 |
Arginase deficiency in Macaca fascicularis. I. Arginase activity and arginine concentration in erythrocytes and liver. |
causal interaction
unassigned |
1
0 |
| 3.5.3.1 | Hyperargininemia |
4625814 |
Arginase deficiency in Macaca fascicularis. I. Arginase activity and arginine concentration in erythrocytes and liver. |
causal interaction
unassigned |
1
0 |
| 3.5.3.1 | Cholecystitis, Acute |
4661849 |
[Serum and liver arginase activity in acute cholecystitis] |
diagnostic usage
ongoing research
unassigned |
4
3
0 |
| 3.5.3.1 | Liver Diseases |
4663759 |
[Enzyme determination by radiochemical methods: serum arginase and its clinical use in liver diseases] |
ongoing research
unassigned |
3
0 |
| 3.5.3.1 | Pancreatitis |
4710424 |
[Rat liver arginase activity in acute experimental pancreatitis] |
diagnostic usage
ongoing research
unassigned |
1
4
0 |
| 3.5.3.1 | Cholecystitis, Acute |
4722321 |
[Changes of serum arginase in patients with acute cholecystitis and pancreatitis] |
causal interaction
diagnostic usage
ongoing research
unassigned |
3
4
3
0 |
| 3.5.3.1 | Pancreatitis |
4722321 |
[Changes of serum arginase in patients with acute cholecystitis and pancreatitis] |
causal interaction
diagnostic usage
ongoing research
unassigned |
3
4
3
0 |
| 3.5.3.1 | Brain Diseases |
5015509 |
[Activity of serum arginase in liver cirrhosis. Its special study in the hemorrhagic syndrome and cirrhogenic encephalopathies] |
ongoing research
unassigned |
2
0 |
| 3.5.3.1 | Liver Cirrhosis |
5015509 |
[Activity of serum arginase in liver cirrhosis. Its special study in the hemorrhagic syndrome and cirrhogenic encephalopathies] |
ongoing research
unassigned |
2
0 |
| 3.5.3.1 | Liver Diseases |
5023366 |
[Arginase activity in cardiopulmonary diseases. Value of its study in statistic liver diseases] |
diagnostic usage
unassigned |
3
0 |
| 3.5.3.1 | Hepatitis |
5160572 |
[Serum arginase activities in acute hepatitis. 3] |
causal interaction
diagnostic usage
unassigned |
4
2
0 |
| 3.5.3.1 | Diabetes Mellitus, Experimental |
5282754 |
[The activity of arginase in salivary glands of rats with alloxan diabetes] |
ongoing research
unassigned |
2
0 |
| 3.5.3.1 | Carcinoma |
5307510 |
Studies on liver arginase in mice with Ehrlich carcinoma. |
ongoing research
therapeutic application
unassigned |
4
1
0 |
| 3.5.3.1 | Carcinoma |
5307536 |
Effect of an alkylating agent on liver arginase in normal and Ehrlich carcinoma bearing mice. |
ongoing research
unassigned |
4
0 |
| 3.5.3.1 | arginase deficiency |
5438971 |
[Hyperargininemia wityh arginase deficiency. A new familial metabolic disease. I. Clinical studies] |
unassigned |
0 |
| 3.5.3.1 | Hyperargininemia |
5438971 |
[Hyperargininemia wityh arginase deficiency. A new familial metabolic disease. I. Clinical studies] |
unassigned |
0 |
| 3.5.3.1 | Metabolic Diseases |
5438971 |
[Hyperargininemia wityh arginase deficiency. A new familial metabolic disease. I. Clinical studies] |
unassigned |
0 |
| 3.5.3.1 | arginase deficiency |
5438972 |
[Hyperargininemia with arginase deficiency. A new familial metabolic disease. II. Biochemical studies.] |
unassigned |
0 |
| 3.5.3.1 | Hyperargininemia |
5438972 |
[Hyperargininemia with arginase deficiency. A new familial metabolic disease. II. Biochemical studies.] |
unassigned |
0 |
| 3.5.3.1 | Metabolic Diseases |
5438972 |
[Hyperargininemia with arginase deficiency. A new familial metabolic disease. II. Biochemical studies.] |
unassigned |
0 |
| 3.5.3.1 | Myocardial Infarction |
5449817 |
[Clinical value of arginase activity determination in human blood serum: diagnosis of myocardial infarction] |
diagnostic usage
ongoing research
unassigned |
4
2
0 |
| 3.5.3.1 | Myocardial Infarction |
5525184 |
Occurrence of arginase in human blood serum in patients with myocardial infarction. |
diagnostic usage
ongoing research
unassigned |
4
4
0 |
| 3.5.3.1 | Carcinogenesis |
5581293 |
Arginase and glucose-6-phosphate dehydrogenase activities in spontaneous mammary carcinogenesis. |
causal interaction
unassigned |
2
0 |
| 3.5.3.1 | Hepatitis |
5597948 |
[Significance of determining arginase activity in epidemic hepatitis] |
causal interaction
diagnostic usage
unassigned |
1
3
0 |
| 3.5.3.1 | Carcinoma |
5674790 |
Hepatic arginase activity in mice bearing Ehrlich ascites carcinoma. |
diagnostic usage
ongoing research
unassigned |
2
3
0 |
| 3.5.3.1 | Hyperthyroidism |
5712375 |
[Inhibition with ethionine and puromycin of the increase of hepatic arginase and urea excretion in hyperthyroid rats] |
causal interaction
unassigned |
1
0 |
| 3.5.3.1 | Cholestasis |
5802091 |
[Changes in arginase activity in various types of experimental cholestasis] |
ongoing research
therapeutic application
unassigned |
3
1
0 |
| 3.5.3.1 | Papilloma |
6022698 |
On the arginase of the Shope papillomas. |
ongoing research
unassigned |
1
0 |
| 3.5.3.1 | Tumor Virus Infections |
6053146 |
Studies on the arginase activity of Shope papilloma: possible presence of isozymes. |
diagnostic usage
ongoing research
unassigned |
1
2
0 |
| 3.5.3.1 | Infections |
6150530 |
Serum gamma glutamyl transpeptidase activity in cattle with induced fascioliasis. |
causal interaction
diagnostic usage
unassigned |
1
3
0 |
| 3.5.3.1 | Carcinoma |
6189588 |
Arginase activity in prostatic tissue of patients with benign prostatic hyperplasia and prostatic carcinoma. |
causal interaction
diagnostic usage
ongoing research
unassigned |
4
2
4
0 |
| 3.5.3.1 | Neoplasms |
6189588 |
Arginase activity in prostatic tissue of patients with benign prostatic hyperplasia and prostatic carcinoma. |
causal interaction
diagnostic usage
ongoing research
unassigned |
4
2
4
0 |
| 3.5.3.1 | Prostatic Hyperplasia |
6189588 |
Arginase activity in prostatic tissue of patients with benign prostatic hyperplasia and prostatic carcinoma. |
causal interaction
diagnostic usage
ongoing research
unassigned |
4
2
4
0 |
| 3.5.3.1 | Blister |
6195857 |
Arginase activity and polyamine biosynthesis in psoriasis. |
causal interaction
diagnostic usage
ongoing research
unassigned |
1
2
4
0 |
| 3.5.3.1 | Psoriasis |
6195857 |
Arginase activity and polyamine biosynthesis in psoriasis. |
causal interaction
diagnostic usage
ongoing research
unassigned |
1
2
4
0 |
